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Abstract 
Mushrooms have been widely used as medicine in the treatment of several infections and also boosting the 
immune system. The present study was carried out to ascertain the haematological and the antioxidants 
properties of aqueous extracts of Agaricus bisporus and Pleurotus tuber-regium. Twenty five albino rats were 
grouped into five, each group consisting of five rats of A to E. Group A serves as the control, group B to D were 
fed with Pleurotus tuber-regiumin 400mg, 600mg and 1000mg concentration respectively while group E was fed 
with 400mg of Agaricus bisporus. On completion of the administration of extracts, the haematological profiles 
and antioxidant parameters were analysed. The experimental rats showed some little significant increase in both 
the haematological profile and biomarkers properties with P<0.05, Generally the haematological profiles implies 
that there was no significant decrease in the level of the experimental rats immunity and also some organs such 
as the liver and the kidney were intact. SOD, CAT, GSH and MDA are antioxidant enzymes measured to detect 
toxic consequences of oxidative stress in mammalian systems. The SOD values in rats treated with 400mg/kg/lb 
of SOD is 113.58mm/mg/protein and rats treated with1000mg/kg in pleuntus tuberregium, the values of MDA is 
23.32±2.09 (nmol/ml). There was a significant difference in the liver homogenated and kidney homogenated 
biomarkers in the rats treated with Pleurotus tuber regium and Agaricus bisporous. They are cellular and 
enzymatic defenses against oxidative stress. Oxidative stress causes toxic and adaptive responses within a cell. 
The importance of an antioxidant defenses in protecting cells and organisms from oxidative damage and toxicity. 
Further research with higher dosage of the extracts may be required to test on laboratory rats before providing 
the true haematological and antioxidant properties. 
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INTRODUCTION 
Mushrooms are macro fungi with distinctive fruiting and they are made up of hyphae which forms interwoven 
web of tissues known as mycelium in the substrates upon which the fungi feed. Most often, their mycelium are 
buried in the soil around the root of trees beneath leaf litters in the tissues of a tree trunk, on a fallen log of wood 
or in their nourishing substrates (Ingold, 1993). Mushrooms can be hypogeous or epigeous, large enough to be 
seen with naked eyes and can be picked up by hands (Chang and Miles, 1992). 
Mushrooms are of great economic importance to man; their occurrence is dated back to the time of 
early man as mushroom appears in traditional Yoruba art works knows as (tie and die) which are materials of 
traditional customes (Adenle, 1985). They have long been used a valuable food source and as traditional 
medicine around the world. Many genera of mushrooms are edible and are rich in essential nutrients such as 
carbohydrates, protein, vitamins, minerals, fats, fibres and various acids (Okwlehie and Odunze, 2004). Records 
of health promoting properties such as antioxidants, anti-microbial, anti-cancer, cholesterol lowering and 
immune-stimulatory effect have been reported for some species of mushrooms (Mau et al., 2004). However it 
must be emphasized that some of these mushroom species are poisonous and may claim lives within few hours 
after consumption (Philips, 1985). Mushrooms have become attractive as a functional food and as a source for 
the development of drugs and neutrceuticals (Lakhanpal and Rana, 2005), responsible with their antioxidants, 
antitumor (Jones and Jonardhanan, 2000) and antimicrobial properties. Mushrooms are becoming more 
important in our diet due to their nutritional value, related to high protein and low fats/energy contents (Agahar-
murugkar and Subbulakshmi, 2005). 
Considering mushrooms growth requirements, they grow well on a wide range of lignocellulostic 
wastes as substrates, has been established that they grow and fruit on various agricultural wastes (Moncalo et al., 
2005). Furthermore, some of these mushrooms have been cultivated in the laboratory (Kadiri, 1994; Fasidi, 
1995). The substrates could be used in commercial production of mushrooms for food (Fasidi, 1995). 
Immunity refers to the protection against infection. The immune system is a collection of cells, tissues 
and molecules that function to defend our body against infectious microbes. The coordinated reaction of the 
immune system against infection and other foreign substances is known as immune response. Abnormalities of 
the immune system that result in defective immune response makes individual susceptible to infection by virus, 
bacteria, fungi and parasites. The antimicrobial defence function of the immune system is essential for our ability 
to survive in an environment that is teeming with potentially deadly microbes. However, immune responses are 
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also capable of causing diseases or damages. Many diseases are caused by uncontrolled and excessive responses 
(examples include rheumatic fever, asthma, glomerulonephritis). 
The immune system of human has the essential function of protecting the body against the damaging 
effect of microbial agents which is pathogenic. The system comprises of innate immunity (nonspecific), and 
acquired immunity (specific). Natural killer (NK) cells, complement system, macrophages, antigen presenting 
cells (APCs) and neutrophils makes up the innate immune response system and mount an immediate nonspecific 
response to foreign microbial agents. Apart from the natural mechanisms there are additional factors that 
stimulate and support host immunity. Immunostimulants enhances the overall immunity of the host, and present 
a nonspecific response against the microbial. They also work to heighten humoral and cellular immune responses 
by either enhancing cytokines secretion or by directly stimulating B-lymphocyte or T-lymphocyte (Benny and 
Vanitha, 2004). 
Antioxidants have been widely used as food additives to provide protection against oxidative 
degradation of food by free radicals. Oxidation is essential to many living for the production of energy to fuel 
biological processes. However, the uncontrolled production of oxygen derived from free radicals is involve in 
the onset of many diseases such as cancer, rheumatoid arthritis and atherosclerosis as well as in degenerative 
processes associated with aging. Almost all organisms are well protected from free radicals damage by enzyme 
such as superoxide dismutase and catalase or compounds such as ascorbic acid, tocophenols and glutathione 
(Mau et al., 2004).  
 
MATERIALS AND METHODS 
Procurement of mushrooms and preparation of aqueous extract 
The mushroom (Agaricus bisporus) was obtained from Ikorodu, area and also Oyster mushroom (Pleurotus 
tuber- regium) was obtained from Ifo area of Ogun state. They were cut into smaller pieces and shade dried 
separately for few days and extraction was carried out with a sterile distilled water in a soxhlet apparatus, the 
residue was filtered and concentrated to dry mass which was weighed and used to prepare the require 
concentration (400mg, 600mg, and 1000mg). 
 
Experimental design 
Male albino rats of Wister strain weighing approximately 310+ 6 kg were used. A total of thirty Albino male rats 
were raised in the animal house of Biological science, Yaba College of Technology, Yaba, Lagos. The animals 
were fed with rat pellets and water was available, adlibitum. 
The animals were divided into five groups (A, B, C, D, and E). The concentration of the mushroom 
extract ranges from 400mg/kg bw, 600mg/kg bw, 800mg/kg bw and 1000mg/kg bw. Group A serve as the 
control while Group E were fed with 400ml/kg bw of Agaricus bisporus. The Extract administration were carried 
out orally using cannulating tube. The rat were sacrified by the method of cervical dislocation 
 Blood samples were obtained from orbitical plexus venus by means of fine capillary glass tubes in 
accordance to the method described by Schermer,(1997). The blood samples were placed in a dry and clean 
centrifuge tubes and 20µl liter of anticouagulatant was added and mixed properly. Serum was removed using a 
Pasteur pipette and centrifuged for twenty minutes at 1100xg. The clean supernatant serum was kept frozen until 
analysed. Body weights of the animals were recorded at the start and the end.  
 
Haematological parameters 
Three rats from each of the treatment groups were sacrificed at the end of the 4
th
 week. The animals were 
anaesthetized with chloroform for 30 seconds. The jugular vein was cut open and blood collected with syringes 
into bottles containing EDTA and into heparinized bottles. The blood samples were spurned in the centrifuge at 
3.000rpm and the haematological indices examined include Red Blood Count (RBC), White Blood Cell (WHC), 
Packed Cell Volume (PCV), leucocytes, differential count (monocyte, lymphocytes etc.) and haemoglobin 
concentration (Hb). 
 
Packed Cell Volume (PCV) Determination 
This was determined by spinning about 751 of each blood samples in heparinized capillary tube I a centrifuge for 
5 minutes. 
 
Erythrocyte (RBC) and Leucocytes (WBC) Counts 
Erythrocyte and Leucocytes Counts were determined using Neubaur chamber method as described by (Lamb, 
1981). The blood sample collected in each treatment was diluted at a ratio of 1:200 for RBC counter using red 
cell diluting fluid while a dilution ratio of 1:20 (blood: white cell diluting fluid) was used for WBC count. 
Samples of RBC WBC count were obtained using the relationship: 
RBC/µL=Number of red blood cells counted x 5 x 10 x200 
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WBC/µ=Number of white blood cells counted x 0.25 x 10x 20 
Haemoglobin (Hb) Estimation 
Haemoglobin was estimated using cyanomethaemoglobin method. 0.02ml of blood was expelled into 4ml 
solution. The mixture was allowed to stand for 5 minutes for fully colour development. Sample haemoglobin 
concentration: 0Sample haemoglobin (g/100ml) = Reading of test x standard haemoglobin concentration. 
 
Biomarkers Test 
Biomarkers activities was tested for superoxide dismutase (SOD), Glutathione peroxide, lipid peroxidative and 
Catalase activity in accordance with zigma procedure of (1978) were carried out in liver and kidney. 
 
Histological Examinations 
Small specimens of the organs of liver and kidney were taken from each experimental group, fixed in neutral 
buffered formalin, dehydrated in ascending concentration of ethanol (70, 80 and 90%), cleared in zylene and 
embedded in paraffin. Sections of 4-6 µm thickness were prepared and stained with hematoxylin and eosin 
according to Bancroft et al., (1996) 
 
Statistical Analysis 
Data were analysed as mean + standard deviation. Student’s “t” test was used to compare the differences 
between control and experimental groups. Excel software were used to determine the “t” and probability (P) 
values.  P < 0.05 was considered as statistically significant.   
 
RESULTS AND DISCUSSION 
TABLE 1: HAEMOGLOBIN CONCENTRATION (g/dl) WITH MEAN±SD OF RATS 
GROUPS Concentration MEAN HB +SD t-VALUE P-VALUE 
A Control 13.6 ± 1.03 26.363 .000 
B Pleurotus tuber-regium 400mg 11.4 ± 0.14 114.000 .006 
C Pleurotus tuber-regium 600mg 9.9± 2.98 5.766 .029 
D Pleurotus tuber-regium 1000mg 12.7 ± 0.77 33.157 .000 
E Agaricus bisporous 400mg 11.1 ±  3.35 7.385 .002 
 
Table 2: PACK CELL VOLUME (%) WITH MEAN±SD OF RATS 
GROUPS Concentration MEAN PCV %+SD t-VALUE P-VALUE 
A Control 41.0 ± 3.27 25.107 .000 
B Pleurotus tuber-regium 400mg 34.5 ± 0.707 69.000 .009 
C Pleurotus tuber-regium 600mg 30.7± 9.29 5.717 .029 
D Pleurotus tuber-regium 1000mg 38.5 ± 2.38 32.346 .000 
E Agaricus bisporous 400mg 33.8 ±  10.56 7.151 .002 
 
Table 3: WHITE BLOOD CELL COUNT (mm
3
) WITH MEAN±SD OF RATS 
GROUPS Concentration MEAN WBC %+SD t-VALUE P-VALUE 
A Control 8600.0 ± 1622.24 10.603 .002 
B Pleurotus tuber-regium 400mg 2625.0 ± 742.46 5.000 .126 
C Pleurotus tuber-regium 600mg 7000.0± 4222.26 2.872 .103 
D Pleurotus tuber-regium 1000mg 9537.5 ± 1949.09 9.787 .002 
E Agaricus bisporous 400mg 6380.0 ±  2477.55 5.758 .005 
 
Table 4: RED BLOOD CELL COUNT (10
6
/ml) WITH MEAN±SD OF RATS 
GROUPS Concentration MEAN RBC +SD t-VALUE P-VALUE 
A Control 3.5 ± 0.13 53.447 .000 
B Pleurotus tuber-regium 400mg 3.9 ± 1.41 3.900 .160 
C Pleurotus tuber-regium 600mg 3.9± 1.63 4.190 .053 
D Pleurotus tuber-regium 1000mg 4.9 ± 1.36 7.230 .005 
E Agaricus bisporous 400mg 3.1 ± 0.81 8.532 .001 
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Table 5: MEAN CELL VOLUME (fl) WITH MEAN±SD OF RATS 
GROUPS Concentration MEAN MCV    +SD t-VALUE P-VALUE 
A Control 118.9 ± 8.99 26.448 .000 
B Pleurotus tuber-regium 400mg 94.3 ± 32.39 4.118 .152 
C Pleurotus tuber-regium 600mg 81.6± 13.96 10.120 .010 
D Pleurotus tuber-regium 1000mg 84.2 ± 30.39 5.538 .012 
E Agaricus bisporous 400mg 112.7 ± 33.72 7.472 .002 
 
Table 6: MEAN CELL HAEMOGLOBIN (pg) WITH MEAN±SD OF RATS 
GROUPS Concentration MEAN MCH +SD t-VALUE P-VALUE 
A Control 39.2 ± 2.82 27.847 .000 
B Pleurotus tuber-regium 400mg 31.1 ± 10.89 4.039 .155 
C Pleurotus tuber-regium 600mg 26.4± 4.55 10.057 .010 
D Pleurotus tuber-regium 1000mg 27.8 ± 9.84 5.657 .011 
E Agaricus bisporous 400mg 36.9 ± 10.76 7.674 .002 
 
Table 7: MEAN CELL HAEMOGLOBIN (g/dl) CONCENTRATION WITH MEAN±SD OF RATS 
GROUPS Concentration MEAN MCHC +SD t-VALUE P-VALUE 
A Control 32.9 ± 0.28 239.489 .000 
B Pleurotus tuber-regium 400mg 32.9 ± 0.21 219.667 .003 
C Pleurotus tuber-regium 600mg 32.4± 0.06 973.000 .000 
D Pleurotus tuber-regium 1000mg 33.1 ± 0.25 262.655 .000 
E Agaricus bisporous 400mg 32.8 ± 0.36 205.250 .000 
 
Table 8: NEUTROCYTE COUNT (%) WITH MEAN±SD OF RATS 
GROUPS Concentration MEAN NEUT %+SD t-VALUE P-VALUE 
A Control 70.0 ± 6.68 20.948 .000 
B Pleurotus tuber-regium 400mg 50.3 ± 43.59 2.000 .184 
C Pleurotus tuber-regium 600mg 75.7± 3.21 40.770 .001 
D Pleurotus tuber-regium 1000mg 77.0 ± 2.58 59.644 .000 
E Agaricus bisporous 400mg 80.3 ± 2.42 81.241 .000 
 
Table 9: LYMPHOCYTE COUNT (%) WITH MEAN±SD OF RATS 
GROUPS Concentration MEAN LYMPH %+SD t-VALUE P-VALUE 
A Control 29.8 ± 6.80 8.749 .003 
B Pleurotus tuber-regium 400mg 15.0 ± 13.00 1.999 .184 
C Pleurotus tuber-regium 600mg 23.7± 2.89 14.200 .005 
D Pleurotus tuber-regium 1000mg 22.3 ± 2.06 21.586 .000 
E Agaricus bisporous 400mg 18.8 ± 2.14 21.588 .000 
 
FIGURE 1: MEAN VALUES OF HAEMATOLOGICAL PARAMETERS 
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Table 10: Mean ± SD of Serum Biomarkers 
Parameters Control (A) Pleurotus 
tuber-regium 
400mg (B) 
Pleurotus 
tuber-regium 
600mg (C) 
Pleurotus 
tuber-regium 
1000mg (D) 
Agaricus 
bisporus 400mg 
(E) 
Superoxide 
Dismutase 
(units/min/mg 
protein) 
74.33 ± 
9.79 
 
79.53 ± 
10.08 
 
55.29 ± 
10.37 
 
79.91 ± 
12.71 
 
113.58 ± 
48.06 
 
Catalase 
(units/min/mg 
protein) 
0.49 ± 
0.34 
 
0.57 ± 
0.02 
 
0.60 ± 
0.77 
 
0.13 ± 
0.11 
 
0.72 ± 
0.30 
 
Reduce 
Glutathione (GSH 
µmol/ml) 
0.743 ± 
0.37 
 
0.90 ± 
0.01 
 
0.94 ± 
0.03 
 
0.72 ± 
0.04 
 
0.74 ± 
0.01 
 
Malondialdehyde 
(nmol/ml) 
27.73 ± 
1.03 
 
27.46 ± 
0.27 
 
28.04 ± 
0.88 
 
32.34 ± 
16.74 
 
23.32 ± 
2.09 
 
 
Table 11: Mean ± SD of Liver Homogenate Biomarkers 
Parameters Control (A) Pleurotus tuber-
regium 400mg 
(B) 
Pleurotus tuber-
regium 600mg 
(C) 
Pleurotus tuber-
regium 1000mg 
(D) 
Agaricus 
bisporus 400mg 
(E) 
Superoxide 
Dismutase 
(units/min/mg 
protein) 
621.49 ±  
189.53 
 
502.13 ± 
30.82 
 
557.14 ± 
63.02 
 
566.86 ± 
57.45 
 
501.97 ± 
56.10 
 
Catalase 
(units/min/mg 
protein) 
8.89 ± 
7.99 
 
1.13 ± 
0.44 
 
5.77 ± 
4.43 
 
2.30 ± 
1.32 
 
3.81 ± 
1.73 
 
Reduce 
Glutathione 
(GSH µmol/ml) 
0.98 ± 
0.46 
 
0.92 ± 
0.24 
 
0.69 ± 
0.02 
 
0.80 ± 
0.41 
 
0.57 ± 
0.05 
 
Malondialdehyde 
(nmol/ml) 
23.32 ± 
1.87 
 
23.97 ± 
1.35 
 
27.06 ± 
4.15 
 
23.12 ± 
1.09 
 
24.90± 
1.89 
 
 
Table 12: Mean ± SD of Kidney Homogenate Biomarkers 
Parameters Control (A) Pleurotus tuber-
regium 400mg 
(B) 
Pleurotus tuber-
regium 600mg 
(C) 
Pleurotus tuber-
regium 1000mg 
(D) 
Agaricus 
bisporus 400mg 
(E) 
Superoxide 
Dismutase 
(units/min/mg 
protein) 
402.08 ± 
34.72 
 
 
408.93 ± 
26.87 
 
399.96 ± 
56.06 
 
495.41 ± 
42.28 
 
443.00 ± 
69.02 
 
Catalase 
(units/min/mg 
protein) 
1.99 ± 
1.46 
 
4.53 ± 
0.57 
 
4.23 ± 
1.44 
 
5.68 ± 
3.04 
 
4.50 ± 
2.67 
 
Reduce 
Glutathione 
(GSH µmol/ml) 
0.91 ± 
0.13 
 
0.85 
 ± 
0.05 
 
0.77 ± 
0.04 
 
0.87± 
0.06 
 
0.88 ± 
0.06 
 
Malondialdehyde 
(nmol/ml) 
24.67 ± 
1.45 
 
25.85 ± 
1.89 
 
23.33 ± 
0.10 
 
25.17 ± 
0.78 
 
24.88 ± 
2.03 
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FIGURE 2: MEAN VALUES OF ANTIOXIDANTS PARAMETERS 
 
MEAN VALUES OF SERUM BIOMARKERS 
 
 
MEAN VALUES OF LIVER HOMOGENATE BIOMARKERS 
 
MEAN VALUES OF KIDNEY HOMOGENATE BIOMARKERS 
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Plate i. Light micrograph of the liver of rat treated with 400 mg/kg bw of Pleurotus tuber-regium 
 
 
Plate ii.  Light micrograph of the kidney of rat treated with 400 mg/kg bw of Pleurotus tuber-regium 
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Plate iii. Light micrograph of the liver of rat treated with 400 mg/kg bw of Agaricus bisporus 
 
 
Plate iv.  Light micrograph of the kidney of rat treated with 400 mg/kg bw of Agaricus bisporus 
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Plate v. Light micrograph of the liver of rat treated with distilled water 
 
 
Plate vi.  Light micrograph of kidney of rat untreated (control) 
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Plate vii.  Light micrograph of liver of rat untreated liver 
 
Discussion 
Two species of mushroom provided (Pleurotus tuber-regium and Agaricus bisporus), at the end the 4
th 
week 
boost the immune system. The mushrooms had immune modulatory properties and also antioxidant properties 
(Mau et al., 2004). 
The effect of the mushroom extract were observed on the haematological parameters as shown in 
tables 1, 2 3 and 4. 
Histopathology examinations review that the rat treated with the two species of mushroom does not 
show any abnormal growth either at the liver or in the kidney as shown in plates 1-5.  
The mean values of Biomarkers Parameters of rats in different treatment regimen. Lipid peroxidation 
products (MDA), superoxide dismutase (SOD), Catalase Activity (CAT), Glutathione reductase (GSH) are 
antioxidants enzymes measured to detect toxic consequences of oxidative stress in mammalian systems (Sue et 
al., 1998). They are cellular and enzymatic defenses against oxidative stress (Winston and Giulio, 1991). 
Oxidative stress causes toxic and adaptive responses within a cell. Several studies have demonstrated the 
importance of an antioxidant defenses in protecting cells and organisms from oxidative damage and toxicity 
(Furono et al., 1996). 
The serum biomarkers, superoxide dismutase shows increase in rats administered with 400mg/kg bw 
and 1000mg/kg bw Pleurotus tuber-regium and decrease in rats administered with 600mg/kg bw Pleurotus 
tuber-regium and 400mg/kg bw Agaricus bisporus when compared with the control group. The increase are 
statistically significant with P<0.05. Superoxide dismutases (SODs) are enzymes that scavenge Oxygen (O2) by 
a rapid dismutation reaction, the activity of SOD leads to production of hydrogen peroxide that is required by 
catalase (Iyawe and Onigbinde 2004). These may have explained the observed raise in the activities of these 
enzymes. 
Catalase is a common enzyme found in living organisms. Its function includes catalyzing the 
decomposition of hydrogen-peroxide to water and oxygen. Activities of SOD can lead to the production of 
hydrogen peroxide (H2O2) required by catalase which invariably lead to the rise of these enzymes in a diseased 
condition. 
Hydrogen peroxide (H2O2) is a harmful by – product of many normal metabolic processes. To prevent 
damage, it must be quickly converted into other, less dangerous substances (Quinlan et al, 1994). To manage this 
problem, the enzyme catalase is frequently used by cells to rapidly catalyze the decomposition of hydrogen 
peroxide into less reactive gaseous oxygen and liquid water molecules (Krinsky, 1992).  
Glutathione (GSH), a non-enzymatic antioxidant, these enzymes also have high affinity for H2O2 and 
may be important for maintenance of low intracellular levels of H2O2 in the cytosol where catalase levels are low. 
In addition to acting as a reducing agent,   (Anderson et al., 1996), GSH also acts as a substrate or co-substrate in 
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many essential enzymatic reactions, the depletion of GSH during oxidative stress could have a significant impact 
on the antioxidant pose within a cell (Scarpa et al., 1983).  
 Catalase and Glutathione shows increase in rats administered with 400mg/kg bw, 600mg/kg bw 
Pleurotus tuber-regium and 400mg/kg bw Agaricus bisporus when compared with the control group. The 
increase are statistically significant with P<0.05. Malondialdehyde increases in all the groups administered with 
Pleurotus tuber-regium but shows decrease in rats administered with Agaricus bisporus. The increase are not 
statistically significant with P>0.05. 
The liver homogenate biomarkers, superoxide dismutase decreases in all experimental group compared 
to the control group and the decrease are statistically significant with P>0.05. Catalase and Glutathione shows 
decrease in all experimental group compared with control group and the decrease are not statistically significant 
with P>0.05. Malondialdehyde increases in rats administered with 600mg/kg bw Pleurotus tuber-regium and 
400mg/kg bw Agaricus bisporus and there was decrease in rats administered with 400mg/kg bw and 1000mg/kg 
bw Pleurotus tuber-regium compared with the control group. The decrease are not statistically significant with 
P>0.05. 
The biomarkers of kidney homogenate, superoxide dismutase shows increase in rats with 400mg/kg 
bw, 1000mg Pleurotus tuber-regium and 400mg/kg bw of Agaricus bisporus but shows decrease in rats 
administered with 400mg/kg bw Pleurotus tuber-regium when compared with the control group. The increase 
are statistically significant with P<0.05. Catalase shows increase in all experimental rats when compared with 
the control group and the increase is statistically significant with P<0.05. Glutathione shows decrease in all 
experimental rats when compared with control group and the decrease are not statistically significant with 
P>0.05. Malondialdehyde shows increase in rats administered with 400mg and 1000mg/kg bw Pleurotus tuber-
regium but shows decrease in rats administered with 600mg/kg bw Pleurotus tuber-regium and 400mg/kg bw 
Agaricus bisporus when compared to the control group, the decrease are not statistically significant with P>0.05. 
Generally, the experimental rats showed less significant increase in the level of antioxidants and further research 
is needed to be carried out.   
 
CONCLUSION 
Medicinal mushroom has been shown to have immunomodulatory properties and antioxidant properties 
including effects on cancer, infections, allergy, asthma and inflammatory disorder. Mushrooms have been seen 
to contain proteins, carbohydrates, vitamins, mineral constituents and fats in low amount, all of which are 
efficient immune developing and body building sources. 
From the present study, the two species (Pleurotus tuber-regium and Agaricus bisporus) of edible 
mushroom provided has shown their effectiveness on immune system due to the results/analysis. Agaricus 
bisporus should be further tested in higher concentrations. 
It can be concluded that the diverse benefits of mushrooms towards human by the words of the father 
of medicine that is, Hippocrates “Let food be your medicine and medicine be your food”. This saying aptly suits 
mushrooms, as they have tremendous medicinal food, drugs and mineral values; hence they are valuable asset 
for the welfare of human. 
 
RECOMMENDATIONS 
Mushrooms has been used for many centuries, it serves as a major source of medicine for human which has help 
to influence the immune system. It is therefore recommended that: 
• Mushrooms must be well identified depending upon what it is to be treated with.  
• Aqueous and ethanol extraction are the two basic extractions solvent for both mushrooms and plant 
materials, reduced amount of ethanol should be used because it may hamper the immune system. 
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